Physician

Homayoun Tabandeh, M.D.

According to 2025 Medicare claims, Homayoun Tabandeh, M.D. (NPI: 1003861576) practices ophthalmology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is RETINA-VITREOUS ASSOCIATES MEDICAL GROUP PC (NPI: 1134164023; TIN: 953699305) and primary practice location at 91436-9998.

Tabandeh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,838 traditional Medicare patients, billed 55,346 HCPCS/CPT codes, and received $5,706,054 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,334 prescription claims across 282 beneficiaries totaling $139,439 in drug costs, led by Vabysmo (Faricimab-Svoa). Open Payments data shows 12 records totaling $3,619. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,617,728 to $5,706,054. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $62,735 to $139,439. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.9M$5.7M2015 Medicare payment: $1,617,728 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,723,601 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,374,089 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,674,547 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,111,069 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,620,250 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,011,035 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,793,142 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,239,374 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,706,054 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,33314,573$1,617,728
20161,41915,424$1,723,601
20171,38316,837$2,374,089
20181,58319,415$2,674,547
20191,54719,594$3,111,069
20201,43018,755$3,620,250
20211,37918,481$4,011,035
20221,52722,552$4,793,142
20231,68038,532$5,239,374
20241,83855,346$5,706,054

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$108K$216K2015 Drug cost: $62,735 (USD; Tot_Drug_Cst)2016 Drug cost: $72,268 (USD; Tot_Drug_Cst)2017 Drug cost: $71,574 (USD; Tot_Drug_Cst)2018 Drug cost: $116,499 (USD; Tot_Drug_Cst)2019 Drug cost: $132,319 (USD; Tot_Drug_Cst)2020 Drug cost: $215,707 (USD; Tot_Drug_Cst)2021 Drug cost: $179,160 (USD; Tot_Drug_Cst)2022 Drug cost: $153,280 (USD; Tot_Drug_Cst)2023 Drug cost: $184,954 (USD; Tot_Drug_Cst)2024 Drug cost: $139,439 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015187810$62,735
2016201911$72,268
20172191,022$71,574
20182481,299$116,499
20192461,341$132,319
20202441,452$215,707
20212321,257$179,160
20222551,230$153,280
20232811,387$184,954
20242821,334$139,439

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye6473,526$104
92014Established patient complete exam of visual system1,2762,222$100
92012Established patient problem focused exam of visual system6492,877$78
92134Imaging of retina1,8235,736$34
92202Extended exam of the back part of the eye with optic nerve drawing784992$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VabysmoFaricimab-Svoa13364$48,328
Prednisolone AcetatePrednisolone Acetate36914,417$17,022
ProlensaBromfenac Sodium29984$9,920
MoxifloxacinMoxifloxacin Hcl2003,040$3,853
CombiganBrimonidine Tartrate/Timolol17425$3,185

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$3,619Ocular Therapeutix, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Homayoun Tabandeh, M.D.?

Tedicare shows public-source Medicare data for Homayoun Tabandeh, M.D. (NPI 1003861576), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Homayoun Tabandeh, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Homayoun Tabandeh, M.D.?

Homayoun Tabandeh, M.D. is linked to RETINA-VITREOUS ASSOCIATES MEDICAL GROUP PC (billing NPI 1134164023) in the available physician profile data.

Does Homayoun Tabandeh, M.D. have Open Payments data?

Homayoun Tabandeh, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.